The story of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in revenue , its patent expiration created a deluge of https://bookmarkjourney.com/story21415261/sildenafil-and-pharma-a-risky-venture